Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque
出版年份 2020 全文链接
标题
Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque
作者
关键词
-
出版物
CIRCULATION
Volume -, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-10-02
DOI
10.1161/circulationaha.120.049981
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors
- (2019) Magid Awadalla et al. Journal for ImmunoTherapy of Cancer
- Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
- (2019) Yucai Wang et al. JAMA Oncology
- Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study
- (2019) Jair Bar et al. EUROPEAN JOURNAL OF CANCER
- Single-cell immune landscape of human atherosclerotic plaques
- (2019) Dawn M. Fernandez et al. NATURE MEDICINE
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
- (2018) Jeffrey C. Kwong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Statins on Coronary Atherosclerotic Plaques
- (2018) Sang-Eun Lee et al. JACC-Cardiovascular Imaging
- Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A U.S. Food and Drug Administration pooled analysis.
- (2018) Laleh Amiri-Kordestani et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in MiceHighlights
- (2016) Takuya Matsumoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
- (2015) Pamela S. Douglas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
- (2015) Janet Lo et al. Lancet HIV
- Distribution, Determinants, and Normal Reference Values of Thoracic and Abdominal Aortic Diameters by Computed Tomography (from the Framingham Heart Study)
- (2013) Ian S. Rogers et al. AMERICAN JOURNAL OF CARDIOLOGY
- Assessment of progression of coronary atherosclerosis using multidetector computed tomography angiography (mdct)
- (2011) Yasmin S. Hamirani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
- (2011) Stephen J. Nicholls et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started